We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ATHX Athersys Inc

0.00 (0.0%)
Pre Market
Last Updated: 19:00:00
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.101
Ask Price 0.104
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Athersys Inc ATHX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.1018 19:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.0938 - 1.99
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.1018 USD

Athersys Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.17M 61.72M - 5.33M -72.53M -1.18 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Athersys News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ATHX Message Board. Create One! See More Posts on ATHX Message Board See More Message Board Posts

Historical ATHX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.4620.4757990.09380.12332439,554,744-0.3602-77.97%
6 Months0.981.050.09380.158442,695,992-0.8782-89.61%
1 Year0.561.990.09380.27305511,272,277-0.4582-81.82%
3 Years43.7575.750.093816.902,925,182-43.65-99.77%
5 Years48.50110.500.093828.502,427,059-48.40-99.79%

Athersys Description

Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |